The results of the clinical trial COAPT: A Randomized Trial of Transcatheter Mitral Valve Leaflet Approximation in Patients With Heart Failure and Secondary Mitral Regurgitation will be presented on Sunday, September 23, 2018 at the TCT conference in San Diego.
Northwestern Medicine experts are available to comment. They include:
- Patrick M. McCarthy, MD, Executive Director, Bluhm Cardiovascular Institute, Chief of Cardiac Surgery at Northwestern Memorial Hospital and the Heller-Sacks Professor of Cardiothoracic Surgery at Northwestern University Feinberg School of Medicine
- Charles Davidson, MD, Clinical Chief of Cardiology at Northwestern Memorial Hospital, Vice Chair for Clinical Affairs, Department of Medicine and Professor of Medicine (Cardiology) at Northwestern University Feinberg School of Medicine
- Mark Ricciardi, MD, Director, Cardiac Catheterization Labs and Interventional Cardiology, Northwestern Memorial Hospital and Associate Professor of Medicine (Cardiology) at Northwestern University Feinberg School of Medicine. Dr. Ricciardi is the principal investigator of COAPT at Northwestern.
Northwestern Memorial Hospital’s heart and heart surgery program is ranked seventh nationally and first in Chicago, Illinois and the surrounding states by U.S. News & World Report.
The Northwestern Medicine Bluhm Cardiovascular Institute is part of the Northwestern Medicine health system, with multiple sites of care in Chicago and the region. Northwestern Medicine is the shared strategic vision of Northwestern Memorial HealthCare and Northwestern University Feinberg School of Medicine.
To reach any of the Northwestern Medicine experts to discuss COAPT and MitraClip, call Kara Spak, manager, media relations at (312) 593-0596.
RSS